Clinical Trials Directory

Trials / Unknown

UnknownNCT03754595

Application of 2D and 3D Laparoscopy in Laparoscopic Pancreaticoduodenectomy: a Prospective Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Pancreatic cancer is extremely malignant, with a low sensibility to chemotherapy and radiotherapy, and a poor prognosis. Surgical treatment is very important for pancreatic cancer. Laparoscopic pancreatoduodenectomy is a standard radical procedure we are going to compare and discuss the advantages of 2D and 3D Laparoscopic pancreatoduodenectomy in our RCT study.

Detailed description

This study is to compare the efficiency and safety between 2D laparoscopic pancreatoduodenectomy and 2D laparoscopic pancreaticoduodenectomy for pancreatic cancer. We design a prospective randomized study. Patients with malignant pancreatic tumor who underwent pancreatoduodenectomy are recruited to the study. After obtaining informed consent, eligible patients are randomly allocated to 2D laparoscopic or 3D laparoscopic group before the operation day . The outcomes evaluated were hospital stay, and blood loss, radicality of surgery, duration of operation and complication rate.

Conditions

Interventions

TypeNameDescription
PROCEDURE3D Laparoscopic pancreatoduodenectomyPatients with pancreatic cancer treated by 3D Laparoscopic pancreatoduodenectomy
PROCEDURE2D Laparoscopic pancreatoduodenectomy2D Laparoscopic pancreatoduodenectomy

Timeline

Start date
2018-12-01
Primary completion
2019-12-01
Completion
2021-12-01
First posted
2018-11-27
Last updated
2018-11-27

Source: ClinicalTrials.gov record NCT03754595. Inclusion in this directory is not an endorsement.